Intensity Therapeutics (INTS) Share-based Compensation (2022 - 2026)
Intensity Therapeutics' Share-based Compensation came in at $387,000 for Q2 2026, down 39.9% from $644,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Intensity Therapeutics (INTS) Share-based Compensation (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Intensity Therapeutics reported Share-based Compensation of $1.7 million, down 29.6% year-over-year; for FY2025, it came in at $2 million, down 34.9% from FY2024.
- Share-based Compensation carries a three-year compound annual growth rate of 19.6% (FY2022 to FY2025).
- Going back by year, Share-based Compensation was $3.07 million in FY2024 (+119.8%), $1.4 million in FY2023 (+19.6%) and $1.17 million in FY2022.
- The five-year range for quarterly Share-based Compensation is $40,711 (Q3 2022) to $1.16 million (Q1 2024).
- Year-over-year, Share-based Compensation has declined for four consecutive quarters, with an average decline of 2.0% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2023 (growth of 762.2%), and the weakest in Q1 2025 (a decline of 62.3%).
- Business Quant data shows INTS's Share-based Compensation at $387,000 (Q1 2026), $450,000 (Q4 2025) and $471,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Intensity Therapeutics | 10.75 Mn | 10.75 Mn | - | 387,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 387,000.00 |
| Mar 31, 2026 | 387,000.00 |
| Dec 31, 2025 | 450,000.00 |
| Sep 30, 2025 | 471,000.00 |
| Jun 30, 2025 | 644,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | 844,000.00 |
| Sep 30, 2024 | 483,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 423,000.00 |
| Sep 30, 2023 | 351,000.00 |
| Jun 30, 2023 | 312,000.00 |
| Mar 31, 2023 | 312,000.00 |
| Dec 31, 2022 | 627,667.00 |
| Sep 30, 2022 | 40,711.00 |
API Access
Intensity Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "INTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();